RUBICON
NSERubicon Research Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹1,431.40
24.20 (1.72%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹23.58K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
114.4
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹570.75+150.8%
52W High₹1,468.7-2.5%
Current Price
₹1,431.40
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹1,145.12
Upper Circuit₹1,717.68
Reference Price
₹1,431.40
Investment Checklist
Ascending Channel on 1D — target ₹1474.34
Trend: Price above all key MAs — strong uptrend
Volume divergence: Bearish (price up, volume down)
Composite score 41.17 (BUY) with 81.2% confidence
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
81%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend
EMA20
1346.13
EMA50
1209.45
Price Action
MIXED
NEUTRAL
Higher Highs5
Higher Lows5
Lower Highs4
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹1468.70
Support (Below)
₹1370.00
₹1286.30
₹1014.55
₹940.15
₹918.00
Volume Analysis
TrendDECREASING
Change-37.20%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Stop Loss Levels
Fixed Risk
1% Risk₹1417.09
3% Risk₹1388.46
5% Risk₹1359.83
7% Risk (Custom)
₹1331.20Technical Levels
1x ATR (Volatility)₹1361.23
2x ATR (Swing)₹1291.06
3x ATR (Trend)₹1220.89
Immediate Support₹1370.00
Moving Averages
EMA 9 (Short-term)₹1387.86
EMA 20 (Medium-term)₹1346.13
EMA 50 (Trend)₹1209.45
Financials
Financial data not available
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Rubicon Research Limited | ₹1,431.40 | +1.72% | 114.4 | ₹23.58K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for RUBICON
View AllNEWS
positive
Business Standard - Markets 4d ago
Rubicon Research receives two procedural observations after USFDA inspection
Rubicon Research announced that the United States Food and Drug Administration (USFDA) conducted an unannounced inspection of its manufacturing facility located at Pithampur, Madhya Pradesh.
MPTODAYRUBICONHealthcareMedia Entertainment & Publication
positive
Business Standard - Markets 40d ago
Rubicon Research jumps 15% to hit 52-week high on Q4 results, dividend news
Along with its quarterly results, the board recommended a dividend of ₹1.50 per equity share of face value ₹1 each, fully paid up, for the financial year ended March 31, 2026
DIVIDENDJMFINANCILRUBICONVALUEFinancial ServicesHealthcare
NEWS
neutral
Business Standard - Markets 40d ago
Alkali Metals Ltd leads gainers in 'B' group
NIIT Ltd, Lorenzini Apparels Ltd, Deep Polymers Ltd and Rubicon Research Ltd are among the other gainers in the BSE's 'B' group today, 01 June 2026.
ALKALIBSEDEEPINDSLALNIITLTDRUBICONSPALChemicalsConsumer Services